Hitoshi Sezaki

4.4k total citations
152 papers, 3.7k citations indexed

About

Hitoshi Sezaki is a scholar working on Pharmaceutical Science, Molecular Biology and Oncology. According to data from OpenAlex, Hitoshi Sezaki has authored 152 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Pharmaceutical Science, 42 papers in Molecular Biology and 42 papers in Oncology. Recurrent topics in Hitoshi Sezaki's work include Drug Transport and Resistance Mechanisms (38 papers), Advanced Drug Delivery Systems (34 papers) and Drug Solubulity and Delivery Systems (23 papers). Hitoshi Sezaki is often cited by papers focused on Drug Transport and Resistance Mechanisms (38 papers), Advanced Drug Delivery Systems (34 papers) and Drug Solubulity and Delivery Systems (23 papers). Hitoshi Sezaki collaborates with scholars based in Japan, United States and Sweden. Hitoshi Sezaki's co-authors include Mitsuru Hashida, Toshiyasu Sakane, Yoshinobu Takakura, Shinji Yamashita, TANEKAZU NADAI, Shozo Muranishi, Makoto Kataoka, Mitsuru Hashida, Kiichiro Kakemi and Hideaki Tokuda and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Annals of the New York Academy of Sciences and Journal of Hepatology.

In The Last Decade

Hitoshi Sezaki

147 papers receiving 3.5k citations

Peers

Countries citing papers authored by Hitoshi Sezaki

Since Specialization

Citations

This map shows the geographic impact of Hitoshi Sezaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hitoshi Sezaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hitoshi Sezaki more than expected).

Fields of papers citing papers by Hitoshi Sezaki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hitoshi Sezaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hitoshi Sezaki. The network helps show where Hitoshi Sezaki may publish in the future.

Co-authorship network of co-authors of Hitoshi Sezaki

This figure shows the co-authorship network connecting the top 25 collaborators of Hitoshi Sezaki. A scholar is included among the top collaborators of Hitoshi Sezaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hitoshi Sezaki. Hitoshi Sezaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	1330 IL28B GENOTYPE MAJOR AND RELAPSE OF PREVIOUS PEG-IFN/RBV THERAPY ARE THE CONVINCING PREDICTOR OF SUSTAINED VIROLOGICAL RESPONSE IN TELAPREVIR WITH PEG-IFN/RBV THERAPY 2011 ·Journal of Hepatology ·Yoshiyasu Karino, Itaru Ozeki, Jouji Toyota, Michio Imamura, Masataka Tsuge, Kazuaki Chayama, Hitoshi Sezaki, Norio Akuta, H Kumada	2
2	Effect of Experimental Acute Renal and Hepatic Failure on Absorption of Tacrolimus in Rat Small Intestine 2004 ·Drug Metabolism and Pharmacokinetics ·Shigeki Tamura, Atsuo Ohike, Yuji Tokunaga, Rinta Ibuki, Gordon L. Amidon, Hitoshi Sezaki, (unknown)	4
3	Optimized conditions for prediction of intestinal drug permeability using Caco-2 cells 2000 ·European Journal of Pharmaceutical Sciences ·Shinji Yamashita, Tomoyuki Furubayashi, Makoto Kataoka, Toshiyasu Sakane, Hitoshi Sezaki, Hideaki Tokuda	467
4	Transnasal delivery of anticancer drugs to the brain tumor. A new strategy for brain tumor chemotherapy. 1999 ·Drug Delivery System ·Tomotaka Shingaki, Toshiyasu Sakane, Shinji Yamashita, Hitoshi Sezaki, Yoshiharu Tokunaga, Shobu Shibata	10
5	Transnasal Delivery of 5-Fluorouracil to the Brain in the Rat 1999 ·Journal of drug targeting ·Toshiyasu Sakane, Shinji Yamashita, Noboru Yata, Hitoshi Sezaki	72
6	Potential efficacy of gelatin microspheres as a new adjuvant for oral vaccination 1998 ·Shinji Yamashita, Mitsuhiro Nakamura, TANEKAZU NADAI, Hitoshi Sezaki, Takeyuki Kohno, (unknown), Y. Ikada	5
7	Analysis of Drug Permeation Across Caco-2 Monolayer: Implication for Predicting In Vivo Drug Absorption 1997 ·Pharmaceutical Research ·Shinji Yamashita, Yoshihiro Tanaka, (unknown), Yoko Taki, Toshiyasu Sakane, TANEKAZU NADAI, Hitoshi Sezaki	101
8	Quantitative Evaluation of the Gastrointestinal Absorption of Protein into the Blood and Lymph Circulation. 1996 ·Biological and Pharmaceutical Bulletin ·Yasuhiro Tsume, Yoko Taki, Toshiyasu Sakane, TANEKAZU NADAI, Hitoshi Sezaki, Kazuhito Watabe, Takeyuki Kohno, Shinji Yamashita	29
9	Control of Disposition Characteristics of Proteins by Direct Cationization in Mice 1995 ·Pharmacy and Pharmacology Communications ·Takuya Fujita, Yoshinobu Takakura, Hitoshi Sezaki, Mitsuru Hashida	5
10	Comparative Analysis of Percutaneous Absorption Enhancement by d-Limonene and Oleic Acid Based on a Skin Diffusion Model 1994 ·Pharmaceutical Research ·Yasuo Koyama, (unknown), Fumiyoshi Yamashita, Yoshinobu Takakura, Hitoshi Sezaki, Mitsuru Hashida	43
11	Specific Uptake of Succinylated Proteins Via a Scavenger Receptor-Mediated Mechanism in Cultured Brain Microvessel Endothelial Cells 1993 ·Biochemical and Biophysical Research Communications ·Hideaki Tokuda, Seiji Masuda, Yoshinobu Takakura, Hitoshi Sezaki, Mitsuru Hashida	24
12	[Combination chemotherapy with 254-S, ifosfamide and peplomycin for advanced or recurrent cervical cancer]. 1992 ·PubMed ·(unknown), (unknown), (unknown), Yosuke Akamatsu, Hitoshi Sezaki, (unknown), (unknown)	3
13	Hepatic targeting of proteins utilizing carbohydrate recognition mechanism. 1991 ·Drug Delivery System ·(unknown), (unknown), Makiya Nishikawa, Takuya Fujita, Mitsuru Hashida, Hitoshi Sezaki	3
14	Biliary excretion of mitomycin C dextran conjugates in relation to physicochemical characteristics of carrier dextran. 1990 ·Journal of Pharmacobio-Dynamics ·Mitsuru Hashida, Ryo Atsumi, (unknown), (unknown), Yoshinobu Takakura, Hitoshi Sezaki	15
15	Statistical Moment Analysis of Hepatobiliary Transport of Phenol Red in the Perfused Rat Liver 1989 ·Pharmaceutical Research ·Koyo Nishida, (unknown), (unknown), Mitsuru Hashida, Hitoshi Sezaki	35
16	Strategy for tumor targeting by macromolecule-drug conjugates. 1988 ·Drug Delivery System ·Yoshinobu Takakura, Takuya Fujita, Mitsuru Hashida, Hitoshi Sezaki	2
17	Analysis of drug penetration through skin considering donor concentration decrease. 1988 ·Journal of Pharmacobio-Dynamics ·Mitsuru Hashida, Hirokazu Okamoto, Hitoshi Sezaki	23
18	Fate of lipid and encapsulated drug after intramuscular administration of liposomes prepared by the freeze-thawing method in rats. 1985 ·Chemical and Pharmaceutical Bulletin ·(unknown), Yasuhisa Matsukawa, Yoshinobu Takakura, Mitsuru Hashida, Hitoshi Sezaki	9
19	DEVELOPMENT OF BIFUNCTIONAL DELIVERY SYSTEM FOR SELECTIVE TRANSFER OF DRUG INTO LYMPHATICS VIA ENTERAL ROUTE AND TRANSFER MECHANISM 1982 ·Journal of Pharmacobio-Dynamics ·Hiroshi Yoshikawa, Shozo Muranishi, Hitoshi Sezaki	2
20	Studies on the Pharmaceutical Potentiation of Drugs. N. Biopharmaceutical Study on the Derivatives of p-Aminosalicylic Acid. 1967 ·Chemical and Pharmaceutical Bulletin ·Kiichiro Kakemi, Hitoshi Sezaki, SHIKIFUMI KITAZAWA, Katsuhiko Okumura	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact